Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.06 USD | +3.62% | +26.22% | +76.99% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |